Cargando…

Temporal Change in Renoprotective Effect of Tolvaptan on Patients with Heart Failure: AURORA Study

(1) Background: It has been reported that tolvaptan (TLV) has a renoprotective effect in acute decompensated heart failure (ADHF) patients, but whether this effect is continued for a long time is unclear. Thus, we evaluated the time course of the renoprotective effect of TLV, in addition to the prog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nishino, Masami, Egami, Yasuyuki, Tanaka, Akihiro, Kawanami, Shodai, Sugae, Hiroki, Ukita, Kohei, Kawamura, Akito, Nakamura, Hitoshi, Matsuhiro, Yutaka, Yasumoto, Koji, Tsuda, Masaki, Okamoto, Naotaka, Matsunaga-Lee, Yasuharu, Yano, Masamichi, Tanouchi, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879381/ https://www.ncbi.nlm.nih.gov/pubmed/35207249 http://dx.doi.org/10.3390/jcm11040977

Ejemplares similares

Predictors of bleeding events in acute decompensated heart failure patients with antithrombotic therapy: AURORA study
por: Kawanami, Shodai, et al.
Publicado: (2022)

Early vascular healing of ultra-thin strut polymer-free sirolimus-eluting stents in acute coronary syndrome: USUI-ACS study
por: Matsuhiro, Yutaka, et al.
Publicado: (2022)

Clinical impact of right ventricular-pulmonary artery uncoupling on predicting the clinical outcomes after catheter ablation in persistent atrial fibrillation patients
por: Yano, Masamichi, et al.
Publicado: (2022)

Atrial fibrillation type modulates the clinical predictive value of neutrophil-to-lymphocyte ratio for atrial fibrillation recurrence after catheter ablation()
por: Yano, Masamichi, et al.
Publicado: (2020)

Prospective randomized comparison of effect on coronary endothelial and renal function between febuxostat and benzbromarone in hyperuricemic patients with coronary artery disease: EFEF study
por: Nishino, Masami, et al.
Publicado: (2022)

Lowering Uric Acid May Improve Prognosis in Patients With Hyperuricemia and Heart Failure With Preserved Ejection Fraction
por: Nishino, Masami, et al.
Publicado: (2022)

Electrophysiological characteristics of non-pulmonary vein triggers excluding origins from the superior vena cava and left atrial posterior wall: Lessons from the self-reference mapping technique
por: Matsunaga-Lee, Yasuharu, et al.
Publicado: (2022)

Impact of ratio of P-wave duration to P-wave amplitude on recurrent arrhythmia characteristics and low-voltage risk score in paroxysmal atrial fibrillation patients underwent catheter ablation
por: Yano, Masamichi, et al.
Publicado: (2023)

Predictors of cardiac function in acute heart failure patients with mid‐range ejection fraction: AURORA study
por: Yanagawa, Kyosuke, et al.
Publicado: (2019)

One-week Impella CP support for papillary muscle rupture as a bridge to surgery: a case report
por: Kawanami, Shodai, et al.
Publicado: (2023)

Efficacy of functional substrate mapping to identify critical isthmus of atrial tachycardia
por: Egami, Yasuyuki, et al.
Publicado: (2023)

Impact of admission hyperglycaemia on clinical outcomes in non‐diabetic heart failure with preserved ejection fraction
por: Yano, Masamichi, et al.
Publicado: (2021)

Impact of readmissions on octogenarians with heart failure with preserved ejection fraction: PURSUIT‐HFpEF registry
por: Nishino, Masami, et al.
Publicado: (2021)

High density lipoprotein cholesterol / C reactive protein ratio in heart failure with preserved ejection fraction
por: Yano, Masamichi, et al.
Publicado: (2021)

Predictors of recurrence after pulmonary vein isolation in patients with normal left atrial diameter
por: Yano, Masamichi, et al.
Publicado: (2019)

‘Touchdown’ technique during self-expandable transcatheter aortic valve replacement in patient with severe left ventricular outflow tract calcification: a case report
por: Tsuda, Masaki, et al.
Publicado: (2023)

Simple bailout technique using a snare catheter for wire withdrawal during balloon-expandable transcatheter aortic valve implantation: a case report
por: Tsuda, Masaki, et al.
Publicado: (2023)

The C-CAT sign may predict coronary artery perforation in severe calcified lesions during coronary intervention: a case series
por: Kawamura, Akito, et al.
Publicado: (2023)

A short RP tachycardia with alternating ventriculoatrial interval, but identical atrial activation sequence: What is the mechanism?
por: Egami, Yasuyuki, et al.
Publicado: (2020)

WATCHMAN FLX implantation with an extremely small left atrial appendage ostium
por: Yano, Masamichi, et al.
Publicado: (2022)

High-density activation map of atrial tachycardia within left atrial appendage
por: Matsunaga-Lee, Yasuharu, et al.
Publicado: (2022)

Orbital Atherectomy Through Left Main Stent Struts Complicated by Catheter Entrapment and Stent Avulsion
por: Matsuhiro, Yutaka, et al.
Publicado: (2020)

Woven Coronary Artery Anomaly: Optical Coherence Tomography Versus Intravascular Ultrasound
por: Yorifuji, Hiroki, et al.
Publicado: (2020)

Renoprotective effect of tolvaptan in patients with new‐onset acute heart failure
por: Kin, Hiromi, et al.
Publicado: (2020)

Renoprotection by long‐term low‐dose tolvaptan in patients with heart failure and hyponatremia
por: Oka, Tatsufumi, et al.
Publicado: (2021)

A Case of Sudden Cardiac Death due to Pilsicainide-Induced Torsades de Pointes
por: Nakatani, Shimpei, et al.
Publicado: (2014)

Valsalva Aneurysm Filled with Thrombi Mimicking a Cardiac Tumor
por: Lee, Yasuharu, et al.
Publicado: (2012)

Renoprotective Benefit of Tolvaptan in Acute Decompensated Heart Failure Patients With Loop Diuretic-Resistant Status
por: Yamamoto, Tomohiko, et al.
Publicado: (2019)

Implantation of three transcatheter aortic valves for embolization of two valves caused by under-expansion: a case report
por: Tsuda, Masaki, et al.
Publicado: (2020)

Renoprotective Effects of DPP-4 Inhibitors
por: Kawanami, Daiji, et al.
Publicado: (2021)

Earliest datable records of aurora-like phenomena in the astronomical diaries from Babylonia
por: Hayakawa, Hisashi, et al.
Publicado: (2016)

Tolvaptan
por: Rangarajan, Bharath, et al.
Publicado: (2014)

Tolvaptan- and Tolvaptan-Metabolite-Responsive T Cells in Patients with Drug-Induced Liver Injury
por: Gibson, Andrew, et al.
Publicado: (2020)

Prediction factors of tolvaptan effectiveness in patients with refractory ascites complicated with hepatocellular carcinoma
por: Imai, Michitaka, et al.
Publicado: (2020)

Renoprotective effects of garlic
por: Nasri, Hamid
Publicado: (2013)

Renoprotective effects of metformin
por: Nasri, Running Hamid
Publicado: (2013)

The renoprotective effects of sulodexide
por: Olde Engberink, Rik HG, et al.
Publicado: (2016)

Tolvaptan, hyponatremia, and heart failure
por: Zmily, Hammam D, et al.
Publicado: (2011)

Tolvaptan for the Treatment of Refractory Ascites
por: Kurosaki, Masayuki, et al.
Publicado: (2016)

Renoprotection and the Bardoxolone Methyl Story – Is This the Right Way Forward? A Novel View of Renoprotection in CKD Trials: A New Classification Scheme for Renoprotective Agents
por: Onuigbo, Macaulay
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_4m6c5s2dk9emjbbn1aq9tv0brv